RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
218 hedge funds and large institutions have $4.57B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 80 increasing their positions, 46 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+54
Holders Change %
+32.93%
% of All Funds
4.3%
Holding in Top 10
17
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+240%
% of All Funds
0.34%
New
74
Increased
80
Reduced
46
Closed
15
Calls
$157M
Puts
$38.8M
Net Calls
+$118M
Net Calls Change
+$151M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
226
Walleye Trading
New York
| – | -$289K | -3,594 | Closed |
|
|
TI
227
Trexquant Investment
Stamford,
Connecticut
| – | -$262K | -3,267 | Closed |
|
228
Parallax Volatility Advisers
San Francisco,
California
| – | -$201K | -2,499 | Closed |
|
|
TRCT
229
Tower Research Capital (TRC)
New York
| – | -$44K | -545 | Closed |
|
|
LC
230
Lindbrook Capital
Calabasas,
California
| – | -$32K | -400 | Closed |
|
|
CCA
231
Catalyst Capital Advisors
Huntington,
New York
| – | -$7K | -85 | Closed |
|
|
NFG
232
Next Financial Group
Houston,
Texas
| – | -$1K | -12 | Closed |
|